ORCL has stabilised modestly after three weeks of freefall, but the week's most telling detail is that the signals which drove the bearish convergence story are now unwinding — while the stock's peers have recovered ground Oracle has not.
The stock closed Tuesday at $146.55, down just under 1% on the day but still off 11% on the week and 35% on the month. That monthly loss is the one number that puts everything else in context. From its pre-earnings level above $210, the drawdown now exceeds 30%. Where the June 29 stock report noted that peers had rebounded while Oracle had not, that divergence is now sharper: RBRK gained 8% on the week, CRWD rose 12%, SAIL added 14%, and MSFT was roughly flat. and dipped slightly. Oracle fell 11%. The sector is not in distress. Oracle is still being re-rated lower on its own.
The short positioning picture has shifted meaningfully from the June 26 convergence report, and that shift deserves naming directly. Short interest has eased. It reached 1.41% of free float on June 25 — the peak flagged in previous coverage — and has since retreated to 1.30%, with a 3.6% single-day drop on June 30. The month-over-month rise of 16% is still notable, but the week's direction is now net covering, not building. Borrow costs ticked up 22% on the week to 0.48%, which sounds alarming until you remember the absolute level: that's still under half a percent. Availability remains extraordinarily loose at over 7,400% — more than seventy times the shares outstanding available to borrow relative to current short interest. There is no squeeze mechanism here. The bears who were building positions into the earnings collapse have started to trim. The borrow market, despite the cost nudge, is nowhere near stressed.
Options defensiveness has also softened from its extremes, though it hasn't fully normalised. The put/call ratio is running at 1.02, above its 20-day average of 0.95 and about 1.3 standard deviations elevated — meaningful, but well back from the near-2.5 standard deviation reading seen on June 23. The 52-week high is 1.06. Options traders are still more cautious than their recent average, but the panic hedging that defined the first two weeks post-earnings has cooled. The overall short score of 30.1 is at its lowest in the ten-day history shown, down from 31.1 on June 25. The data is, collectively, less bearish than it was — even as the stock continues to drift.
The Street's view is where the real tension lives. Analyst reaction to the June 10 earnings print was extensive — roughly twenty firms responded on June 11 — and the direction was mixed in a way that obscures a stark split. Bulls are genuinely bullish: Guggenheim holds a $400 target, Bernstein raised to $325, TD Cowen reiterated Buy at $300. Bears and neutrals are anchoring much lower: RBC held Sector Perform at $190, Stephens held Equal-Weight at $164. Wedbush cut its target from $275 to $240 while keeping Outperform. The consensus mean of roughly $253 implies more than 70% upside from $146 — a gap that has only widened since the June 29 report noted it was "$103 wide." That gap is not a bullish signal on its own. It reflects the magnitude of the stock's fall relative to a Street that hasn't yet revised targets down to meet the price. The bull case — 41% cloud revenue growth, 243% AI infrastructure demand growth, $90 billion FY27 guidance — remains intact on paper. The bear case centres on competitive pressure from AWS and Azure, foreign exchange exposure, and the risk that AI monetisation expectations are simply too high. Factor scores offer some support: EPS momentum ranks in the 97th percentile on a 30-day basis and 91st percentile over 90 days. The company is still beating estimates. The market, for now, doesn't care.
The insider data adds one more piece to the picture without resolving anything. Executive Vice Chairman Jeffrey Henley sold approximately $61 million in shares across multiple tranches on June 24, at prices between $156 and $165 — well above where the stock trades today. The net 90-day insider figure shows modest net buying at the aggregate level ($66 million net positive in value, $415,000 net shares), but that reading is dominated by whatever buying occurred earlier in the window. The Henley sales at higher prices, while the stock continued lower, are consistent with an executive trimming exposure into strength that never materialised.
What to watch next: the question is whether the gap between the $146 price and the $253 consensus closes from above — via a stock recovery — or from below, as more analysts trim targets toward the current trading range, with the pace of peer outperformance versus Oracle the clearest near-term read on which direction the Street's conviction is moving.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.